Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 337: The FAST-TRACK Study
An open-label individual-level randomized controlled trial to compare point of care HCV RNA testing and nurse-led rapid treatment initiation to standard of care to enhance treatment uptake in persons with hepatitis C in a transient correctional setting
-
CTNPT 048: The MOVE-UP Study
Mapping Opportunities for HPV Vaccination and Screening Engagement and Uptake in Trans Men and Gender Non-Binary Individuals Assigned Female at Birth
-
CTNPT 054: Falls in older persons with HIV
Falls in older persons with HIV: Frequency, risk factors and feasibility of a future interventional trial
-
CTNPT 052: Glycoprotein 120 as a pan-toxin
Exploring the role of the soluble glycoprotein 120 as a pan-toxin driving immune dysfunction and accelerated aging in people living with HIV
-
CTNPT 049: SMART Intervention in Middle Eastern and North African Gay, Bisexual, and Trans Youth
Promoting Mental Health and Reducing HIV Risk Behaviours through Self-compassion, Mindful Acceptance u0026 Resilience Transformation (SMART): An Evidence-informed Pilot Randomized Trial with Diaspora MENA Gay, Bisexual and Trans Youth in Ontario
-
CTN 338: PLATINUM-CAN
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
-
CTN 339: The NOVA-HIV Study
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
-
-
CTNPT 050: Perception of menopausal hormone therapy among women living with HIV
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
-
-
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More